Литература

 1. Rush B. An Inquiry Into the Functions of the Spleen, Liver, Pancreas, and Thyroid Gland. Med Phys J. 1806 Sep; 16(91):193-208.

 2. Gull WW. On a cretinoid state supervening in adult life in women. Trans Clin Soc Lond 1873/1874; 7:180-185.

 3. Ord W. Clinical lecture on myxoedema. The British Medical J. 1878; 1:672-673.

 4. Pearce JMS. Myxoedema and Sir William Withey Gull (1816–1890) J Neurol Neurosurg Psychiatry. 2006; 77(5):639.

 5. Gowans W. History of a case of myxoedema. Br Med J 1882; 1:772-773.

 6. Heron. Case of myxoedema in a man. Br Med J 1882; 1:89.

 7. Oliver T. Clinical lecture on myxoedema. Br Med J 1883; 1:502-504.

 8. Whitwell JR. The. Nervous element in myxoedema. 1892, 27:430-432.

 9. Schiff M. Résumé d’une série d’exéèriences sur les effets d’ablation des corps thyroides. Rev Med Suisse Romande. 1884; 4:65-75:425-445.

10. Schlick T. Organotherapy and organ replacement The origins of organ transplantation. Rochester: University of Rochester Press; 2010; 47-52.

11. Murray GR. Note on the treatment of myxoedema by hypodermic injections of an extract of the thyroid gland of a sheep. The British Medical J. 1891; 10:796-797.

12. Beatty WA. case of myxoedema successfully Treated by massage and hypodermic Injections of the Thyroid gland of a Sheep. The British Medical J. 1892; 12:544-545.

13. Shapland JD. The treatment of myxoedema by feeding with the thyroid gland of the sheep. Br Med J 1893; 8:738-739.

14. Logan MST, Logan JS. The treatment of myxoedema with raw sheep thyroid gland and its introduction into practice in County Londonderry in 1892. The Ulster Medical Journal. 1892, 61, 1:86-93.

15. Kocher ET. Ueber Kropfextirpation und ihre Folgen, Arch klin chir 1883; 29: 254-377.

16. Starling E. Croonian Lecture: On the chemical correlation of the functions of the body I. Lancet 1905; 166: 4275:339-341.

17. Harington CR. Chemistry of Thyroxine: Constitution and Synthesis of Desiodo-Thyroxine. Biochem J. 1926;20(2):300‐313.

18. Harington CR, Barger G. Chemistry of Thyroxine: Constitution and Synthesis of Thyroxine. Biochem J. 1927;21(1):169‐183.

19. Neuberger A. Sir Charles Harington (1897-1972). Biochem J. 1972;129(4):801‐804.

20. Henderson J. Ernest Starling and ‘Hormones’: An Historical Commentary. J Endocrinol. 2005; Jan; 184(1):5-10.

21. Могильницкий БН. в книге Шерешевский НА, Степун ОА, Румянцев АВ. Основы эндокринологии. Учение о внутренней секреции и клиника заболеваний эндокринной системы. Москва-Ленинград: Гос изд биол и мед литературы. 1936; 632.

22. Шерешевский НА. Клиническая эндокринология. М.: Медгиз, 1946; 368.

23. Шерешевский НА. Клиническая эндокринология. М.: Медгиз, 1957; 308.

24. Шервинский ВД, Сахаров ГП, и др. Основы эндокринологии. Л.: Практическая медицина. 1929; 628.

25. Подвысоцкий ВВ. Основы общей и экспериментальной патологии. Руководство к изучению физиологии больного человека. Изд. 4-е. СПб: Издание К.Л Риккера. 1905; 922.

26. Вирхов Р. Целлулярная патология как учение основанное на физиологической и патологической физиологии. Москва. Типография ОБ Миллера. 1865; 402.

27. Научная сессия, посвященная проблемам физиологического учения академика И.П. Павлова. М.: Изд. АН СССР, 1950; 736.

28. Дрезель К. Заболевания вегетативной нервной системы. М.: Мосздравотдел. 1926; 188.

29. Бергман Г. Функциональная патология. М.-Л.: Гос изд биол и мед лит. 1936; 400.

30. Росин ЯА. Физиология вегетативной нервной системы. М.: Наука. 1965; 408.

31. Гельгорн Э. Регуляция функции автономной нервной системы. Их значение для физиологии, патологии и нейропсихиатрии. М.: Гос изд иностр лит. 1948; 416.

32. Вернер С. Гипотиреоидизм. Щитовидная железа. Физиология и клиника. 2-е изд. Л.: Гос изд мед лит. 1963, 452.

33. Hashimoto H. Zur Kenntus der Lymphomatosen veranderung der Schildruse (Struma Lymphomatosa). Arch. f. kin Chir. 1912; 97:219.

34. McClintock JC, Wright AW. Riedel’s struma and struma lymphomatosa (Hashimoto): a comparative study. Ann Surg. 1937; 106(1):11‐32.

35. Reid DRK. Hashimoto’s Disease: A Review. Postgrad Med J. 1951; 27(306):185-195.

36. Riedel BMCL. Die chronische zur Bildung eisenharter Tumoren fuhrende Entzundung der Schilddruse. Verhandl. d. deutsch. Gesellsch. f. Chir., 1896, 25: 101.

37. Graham A. Riedel’s Struma in Contrast to Struma Lymphomatosa (Hashimoto). West. Jour. Surg. 1931, 39, 68I-689.

38. McClintock JC, Wright AW. Riedel’s struma and struma lymphomatosa (Hashimoto): a comparative study. Ann Surg. 1937;106(1):11‐32.

39. Joll, CA Pathology, Diagnosis, and Treatment of Hashimoto’s Disease (Struma Lymphomatosa). Brit. J. Surg. 1939, 27: 351.

40. Reid DR. Hashimoto’s disease: A review. Postgrad Med J. 1951;27(306):185‐195.

41. Marshall SF, Meissner WA. Struma Lymphomatosa (Hashimoto’s Disease). Ann Surg. 1955 May;141(5):737-746.

42. Cameron AT. Recent Advances in Endocrinology. 5-th ed. Blakiston Comp.1945; 415.

43. Rose NR, Witebsky E. Иммуннологические исследования при болезнях щитовидной железы. Иммуннопатология в клинике и эксперименте. Проблема антител. М.: Гос. изд. биол и мед литературы. 1963; 556.

44. Gross J, Pitt-Rivers R The Identification of 3:5:3’-L-triiodothyronine in Human Plasma. Lancet. 1952; 1;1(6705):439-41.

45. Rose NR, Witebsky E. Studies on organ specificity: V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J Immunol 1956, 76:417-427.

46. Witebsky E, Rose NR, Paine JR, et al. Thyroid-specific autoantibodies. Ann N Y Acad Sci 1957; 69:669-677.

47. Roitt IM, Doniach D. Lymphoid thyroiditis as a model for auto-immune disease. Acta Allergol. 1963; 18:474-478.

48. Goudie RB, Anderson JR, Gray KG, Boyle JA, Buchanan WW. Autoimmune associations of Hashimoto’s disease. Lancet. 1965; 1(7380):322‐323.

49. Reinlein JMA, Berastegui VN. Thyroiditis and Autoimmune Mechanisms. Munch Med Wochenschr. 1967; 14;109(15):829-840.

50. Hiromatsu Y, Satoh H, Amino N. Hashimoto’s Thyroiditis: History and Future. Outlook. Hormones (Athens). 2013;12(1):12-18.

51. Utiger RD. Radioimmunoassay of human plasma thyrotropin. J of Clin Investigation 1965; 44: 8, 1277.

52. Odel WD, Wilbur JF, Paul WE. Radioimmunoassay of thyrotropin in human serum. J of Clin Endocrinology and Metabolism 1965; 23: 1179.

53. Odell WD, Wilber JF, Utiger RD. Studies of Thyrotropin Physiology by Means of Radioimmunoassay. Recent Prog Horm Res. 1967;23:47-85.

54. Evered D, Hall R. Hypothyroidism. Br Med J. 1972; 1(5795):290‐293.

55. Utiger RD. Serum Triiodothyronine in Man. Annu Rev Med. 1974; 25:289-302.

56. Pekary AE, Hershman JM, Parlow AF. A Sensitive and Precise Radioimmunoassay for Human Thyroid-Stimulating Hormone. J Clin Endocrinol Metab. 1975;41(4):676-684.

57. Broughton A. Clinical Usefulness of Radioimmunoassay of Thyrotropin: A Review. South Med J. 1976; 69(6):702-704.

58. Pain RW. In Vitro Testing of Thyroid Function: A Review. Pathology. 1975; 7(1):1-12.

59. Мельниченко ГА, Удовиченко ОВ, Шведова АЕ, Витебская АВ. Эндокринология: профессиональные секреты. М.: Практическая медицина. 2019; 168.

60. Walsh JP, Ward LC, Burke V, et al. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial. J Clin Endocrinol Metab. 2006; 91(7):2624‐2630.

61. Stott DJ, Rodondi N, Kearney PM, et al. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med. 2017; 376(26):2534‐2544.

62. de Montmollin M, Feller M, Beglinger S, et al. L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized Trial. Ann Intern Med. 2020;172(11):709‐716.

63. Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. Eur Thyroid J. 2012;1(2):55-71.

64. Bakhteyar H, Cassone C, Kohan HG, Sani SN Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium(T3). Int J Pharm Compd. 2017; 21(5):418-425.

65. Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options. Drugs Context. 2019; 8:212597.

66. Calissendorff J, Falhammar H. To Treat or Not to Treat Subclinical Hypothyroidism, What Is the Evidence? Medicina (Kaunas). 2020; 19;56(1).

67. Midgley JEM, Toft AD, Johannes RL, Dietrich W, Hoermann R Time for a reassessment of the treatment of hypothyroidism. BMC Endocr Disord. 2019; 19:37.

68. Duntas LH Subclinical hypothyroidism: a misnomer in search of a new name. Thyroid. 2001; 11:361-362.

69. Wiersinga WM Guidance in Subclinical Hyperthyroidism and Subclinical Hypothyroidism: Are We Making Progress? Eur Thyroid J. 2015; 4(3):143-148.

70. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: Results of a large, controlled community-based questionnaire study. Clin. Endocrinol. 2002; 57:577–585.

71. Wekking EM, Appelhof B.C., Fliers E., Schene A.H., Huyser J., Tijssen J.G., Wiersinga W.M. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur. J. Endocrinol. 2005; 153:747–753.

72. Walsh JP, Ward LC, Burke V, et al. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial. J Clin Endocrinol Metab. 2006; 91(7):2624‐2630.

73. Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Recent Advances in Thyroid Hormone Regulation: Toward a New Paradigm for Optimal Diagnosis and Treatment. Front Endocrinol (Lausanne). 2017; 22;8:364.

74. Bekkering GE, Agoritsas T, Lytvyn L. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ 2019; 365.

75. Ушаков АВ. Классификации доброкачественных состояний щитовидной железы. Клинический диагноз. М.: Клиника доктора А.В. Ушакова. 2016; 240.

76. Gaitonde DY, Rowley KD, Sweeney LB. Hypothyroidism: an update. Am Fam Physician. 2012; 86(3):244‐251.

77. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017; 390(10101):1550‐1562.

78. Chiovato L, Magri F, Carlé A. Hypothyroidism in Context: Where We’ve Been and Where We’re Going. Adv Ther. 2019; 36(Suppl 2):47‐58.

79. Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options. Drugs Context. 2019; 13;8:212597.

80. Brokhin M, Danzi S, Klein I. Assessment of the Adequacy of Thyroid Hormone Replacement Therapy in Hypothyroidism. Front Endocrinol (Lausanne). 2019; 20;10:631.

81. Сеченов ИМ. Физиология нервной системы. СПб. Типогр. А. Головачева, 1866; 522.

82. Ажипа ЯИ. Нервы желез внутренней секреции и медиаторы в регуляции эндокринных функций. 2-е доп. изд. М.: Наука. 1981; 503.

83. Ушаков АВ. Доброкачественные заболевания щитовидной железы. Клиническая классификация. М.: Клиника доктора А.В. Ушакова. 2013; 384.

84. Ноздрачев АД, Чернышова МП. Рецензия А.В. Ушаков «Доброкачественные заболевания щитовидной железы. Клиническая классификация. М.: Клиника доктора А.В. Ушакова, 2013». Ж. Цитология. 2015; 57 (10): 747-750.

85. Maenhaut C, Christophe D, Vassart G, Dumont J, Roger PP, Opitz R. Ontogeny, Anatomy, Metabolism and Physiology of the Thyroid. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. South Dartmouth (MA): MDText. com, Inc.; 2000.

86. Seifert AW, Muneoka K. The blastema and epimorphic regeneration in mammals. Dev Biol. 2018; 433(2):190‐199.

87. Knox SM, Lombaert IM, Haddox CL, et al. Parasympathetic stimulation improves epithelial organ regeneration. Nat Commun. 2013; 4:1494.

88. Barbul A, Regan MC. Immune involvement in wound healing. Otolaryngol Clin North Am. 1995; 28(5):955‐968.

89. Schäffer M, Barbul A. Lymphocyte function in wound healing and following injury. Br J Surg. 1998; 85(4):444‐460.

90. Park JE, Barbul A. Understanding the role of immune regulation in wound healing. Am J Surg. 2004; 187(5A):11S‐16S.

91. Tsirogianni AK, Moutsopoulos NM, Moutsopoulos HM. Wound healing: immunological aspects. Injury. 2006; 37 Suppl 1:S5‐S12.

92. Koh TJ, DiPietro LA. Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med. 2011; 13:e23. Published 2011 Jul 11.

93. Godwin JW, Pinto AR, Rosenthal NA. Macrophages are required for adult salamander limb regeneration. Proc Natl Acad Sci U S A. 2013; 110(23):9415‐9420.

94. Almandoz JP, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am. 2012; 96(2):203‐221.

95. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004; 84(1):277‐359.

96. Silvestri E, Schiavo L, Lombardi A, Goglia F. Thyroid hormones as molecular determinants of thermogenesis. Acta Physiol Scand. 2005; 184(4):265‐283.

97. Vaitkus JA, Farrar JS, Celi FS. Thyroid Hormone Mediated Modulation of Energy Expenditure. Int J Mol Sci. 2015; 16(7):16158‐16175.

98. Yavuz S, Salgado Nunez Del Prado S, Celi FS Thyroid Hormone Action and Energy Expenditure. J Endocr Soc. 2019 May 16; 3(7):1345-1356.

99. Tsibulnikov S, Maslov L, Voronkov N, Oeltgen P. Thyroid hormones and the mechanisms of adaptation to cold. Hormones (Athens). 2020;10.1007.

100. Yau WW, Yen PM. Thermogenesis in Adipose Tissue Activated by Thyroid Hormone. Int J Mol Sci. 2020; 21(8):3020.

101. Terjung RL, Tipton CM. Plasma thyroxine and thyroid-stimulating hormone levels during submaximal exercise in humans. Am J Physiol. 1971; 220(6):1840‐1845.

102. Rothenbuchner G, Loos U, Kiessling WR, Birk J, Pfeiffer EF. The influence of total starvation on the pituitary-thyroid-axis in obese individuals. Acta Endocrinol Suppl (Copenh). 1973; 173:144.

103. Carter JN, Eastman CJ, Corcoran JM, Lazarus L. Effect of severe, chronic illness on thyroid function. Lancet. 1974; 2(7887):971‐974.

104. Portnay GI, O’Brian JT, Bush J, et al. The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. J Clin Endocrinol Metab. 1974; 39(1):191‐194.

105. Balsam A, Leppo LE. Effect of physical training on the metabolism of thyroid hormones in man. J Appl Physiol. 1975; 38(2):212‐215.

106. Bermudez F, Surks MI, Oppenheimer JH. High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab. 1975;41(1):27‐40.

107. O’Connell M, Robbins DC, Horton ES, Sims EA, Danforth E Jr. Changes in serum concentrations of 3,3’,5’-triiodothyronine and 3,5,3’-triiodothyronine during prolonged moderate exercise. J Clin Endocrinol Metab. 1979; 49(2):242‐246.

108. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Fetal and maternal thyroid hormones. Horm Res. 1987; 26(1-4):12‐27.

109. Joffe RT, Levitt AJ. The Thyroid Axis and Psychiatric Illness. Washington, DC: American Psychiatric Press. 1993; 339.

110. Deligiannis A, Karamouzis M, Kouidi E, Mougios V, Kallaras C. Plasma TSH, T3, T4 and cortisol responses to swimming at varying water temperatures. Br J Sports Med. 1993; 27(4):247‐250.

111. Hackney AC, Davis HC, Lane AR. Growth Hormone-Insulin-Like Growth Factor Axis, Thyroid Axis, Prolactin, and Exercise. Front Horm Res. 2016; 47:1‐11.

112. Chatzitomaris A, Hoermann R, Midgley JE, et al. Thyroid AllostasisAdaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming. Front Endocrinol (Lausanne). 2017; 8:163.

113. de Souza HS, Jardim TV, Barroso WKS, de Oliveira Vitorino PV, Souza ALL, Jardim PCV. Hormonal assessment of participants in a long distance walk. Diabetol Metab Syndr. 2019; 11:19.

114. Kovaničová Z, Kurdiová T, Baláž M, et al. Cold exposure distinctively modulates parathyroid and thyroid hormones in cold-acclimatized and non-acclimatized humans Endocrinology. 2020; bqaa051.

115. Войткевич АА. Восстановительные процессы и гормоны. Л.: Медицина. 1965. 252.

116. Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. 2009; 6:5.

117. Ralls PW, Mayekawa DS, Lee KP, Colletti PM, Radin DR, Boswell WD, Halls JM. Color-flowDoppler sonography in Gravesdisease: “thyroid inferno”. AJR Am J Roentgenol. 1988; 150(4):781-784.

118. Vitti P, Rago T, Mazzeo S, et al. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves’ disease from Hashimoto’s thyroiditis. J Endocrinol Invest. 1995; 18(11):857‐861.

119. Summaria V, Salvatori M, Rufini V, Mirk P, Garganese MC, Romani M. Diagnostic Imaging in Thyrotoxicosis Rays. Apr-Jun 1999;24(2):273-300.

120. Baek HJ, Kim DW, Ryu KH, et al. Thyroid Imaging Reporting and Data System for Detecting Diffuse Thyroid Disease on Ultrasonography: A Single-Center Study. Front Endocrinol (Lausanne). 2019; 10:776.

121. Bogazzi F, Bartalena L, Brogioni S, Burelli A, Manetti L, Tanda ML, Gasperi M, Martino E Thyroidvascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. Eur J Endocrinol. 1999; 140(5):452-456.

122. Schulz SL, Seeberger U, Hengstmann JH. Color Doppler sonography in hypothyroidism. Eur J Ultrasound. 2003;16(3):183‐189.

123. Заболотская НВ, Стрижакова ЕМ. Применение допплерографии для количественной оценки кровотока в щитовидных артериях при хроническом аутоиммунном тиреоидите. Ультразвуковая и функциональная диагностика. 2009; 3: 9-20.

124. Ishay A, Pollak Y, Chervinsky L, Lavi I, Luboshitzky R. Color-flow doppler sonography in patients with subclinical thyroid dysfunction. Endocr Pract. 2010; 16(3):376‐381.

125. Höfling DB, Chavantes MC, Juliano AG, et al. Assessment of the effects of low-level laser therapy on the thyroid vascularization of patients with autoimmune hypothyroidism by color Doppler ultrasound. ISRN Endocrinol. 2012; 2012:126720.

126. Corona G, Biagini C, Rotondi M, et al. Correlation between, clinical, biochemical, color Doppler ultrasound thyroid parameters, and CXCL-10 in autoimmune thyroid diseases. Endocr J. 2008; 55(2):345‐350.

127. Ушаков АВ. Клиническая ультразвуковая диагностика доброкачественной патологии щитовидной железы. М.: Клиника доктора А.В. Ушакова. 2018; 216.

128. Recker S, Voigtländer R, Viehmann A, et al. Thyroid Related Quality of Life in Elderly with Subclinical Hypothyroidism and Improvement on Levothyroxine is Distinct from that in Young Patients (TSAGE). Horm Metab Res. 2019;51(9):568‐574.

129. Iwadate M, Takizawa Y, Shirai YT, Kimura S. An in vivo model for thyroid regeneration and folliculogenesis. Lab Invest. 2018; 98(9):1126‐1132.

130. Gibelli B, El-Fattah A, Giugliano G, Proh M, Grosso E. Thyroid stem cells--danger or resource?. Acta Otorhinolaryngol Ital. 2009; 29(6):290‐295.

131. Thomas D, Friedman S, Lin RY. Thyroid stem cells: lessons from normal development and thyroid cancer. Endocr Relat Cancer. 2008;15(1):51‐58.

132. Klonisch T, Hoang-Vu C, Hombach-Klonisch S. Thyroid stem cells and cancer. Thyroid. 2009; 19(12):1303‐1315.

133. Ozaki T, Matsubara T, Seo D, et al. Thyroid regeneration: characterization of clear cells after partial thyroidectomy. Endocrinology. 2012; 153(5):2514‐2525.

134. Al-Suhaimi EA, Al-Khater K. Functions of stem cells of thyroid glands in health and disease. Rev Endocr Metab Disord. 2019;20(2):187‐195.

135. Toda S, Koike N, Sugihara H. Thyrocyte integration, and thyroid folliculogenesis and tissue regeneration: perspective for thyroid tissue engineering. Pathol Int. 2001; 51(6):403‐417.

136. Toda S, Koike N, Sugihara H. Cellular integration of thyrocytes and thyroid folliculogenesis: a perspective for thyroid tissue regeneration and engineering. Endocr J. 2001; 48(4):407‐425.

137. Jonklaas J. Risks and safety of combination therapy for hypothyroidism. Expert Rev Clin Pharmacol. 2016; 9(8):1057‐1067.

138. Saxena SK, Thompson JS, Sharp JG. Role of epidermal growth factor in intestinal regeneration. Surgery. 1992; 111(3):318‐325.

139. Carlson BM. Some principles of regeneration in mammalian systems. Anat Rec B New Anat. 2005; 287(1):4‐13.

140. King RS, Newmark PA. The cell biology of regeneration. J Cell Biol. 2012;196(5):553‐562.

141. Chi C, Trinkaus-Randall V. New insights in wound response and repair of epithelium. J Cell Physiol. 2013; 228(5):925‐929.

142. Seifert AW, Muneoka K. The blastema and epimorphic regeneration in mammals. Dev Biol. 2018; 433(2):190‐199.

143. Ohgo S, Ichinose S, Yokota H, Sato-Maeda M, Shoji W, Wada N. Tissue regeneration during lower jaw restoration in zebrafish shows some features of epimorphic regeneration. Dev Growth Differ. 2019; 61(7-8):419‐430.

144. Coclet J, Foureau F, Ketelbant P, Galand P, Dumont JE. Cell population kinetics in dog and human adult thyroid. Clin Endocrinol (Oxf). 1989; 31(6):655‐665.

145. Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 1992; 72(3):667‐697.

146. Chen CY, Kimura H, Landek-Salgado MA, et al. Regenerative potentials of the murine thyroid in experimental autoimmune thyroiditis: role of CD24. Endocrinology. 2009; 150(1):492‐499.

147. Bychkov A. Epithelial hyperplasia is responsible for the compensatory enlargement of remaining thyroid lobe after thyroidectomy. Eur Arch Otorhinolaryngol. 2018; 275(9):2417‐2419.

148. Pustelnik FS, Gronbek C, Døssing H, et al. The compensatory enlargement of the remaining thyroid lobe following hemithyroidectomy is small and without impact on symptom relief. Eur Arch Otorhinolaryngol. 2018; 275(1):161‐167.

149. Fabre M, Asch L. Activit’e fonctionnelle de r’eg’en’erats thyrouidiens apr’es thyrouidectomie chirurgicale [functional activity of thyroid regenerates after surgical thyroidectomy]. C R Seances Soc Biol Fil. 1963; 157:2073‐2076.

150. Isler H. Role of the hypophysis in thyroid regeneration after partial thyroidectomy. Rev Can Biol. 1979; 38(1):1‐7.

151. Toda S, Aoki S, Suzuki K, et al. Thyrocytes, but not C cells, actively undergo growth and folliculogenesis at the periphery of thyroid tissue fragments in three-dimensional collagen gel culture. Cell Tissue Res. 2003; 312(3):281‐289.

152. Samuels MH. Subacute, silent, and postpartum thyroiditis. Med Clin North Am. 2012; 96(2):223‐233.

153. Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking O, VikMo H. The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid. 2000; 10(3):251‐259.

154. Wu G, Zou D, Cai H, Liu Y. Ultrasonography in the diagnosis of Hashimoto’s thyroiditis. Front Biosci (Landmark Ed). 2016; 21:1006‐1012.

155. Jeong SH, Hong HS, Lee JY. The association between thyroid echogenicity and thyroid function in pediatric and adolescent Hashimoto’s thyroiditis. Medicine (Baltimore). 2019; 98(14):e15055.

156. Yeh HC, Futterweit W, Gilbert P. Micronodulation: ultrasonographic sign of Hashimoto thyroiditis. J Ultrasound Med. 1996; 15(12):813‐819.

157. Baskin Sr HJ, Duick DS, Levine RA, editors. Thyroid ultrasound and ultrasound-guided FNA. 3rd ed. New York: Springer; 2013; 440.

158. Duick DS, Lupo MA, Levine RA. Thyroid and Parathyroid Ultrasound and Ultrasound-Guided FNA. Link. 2018; 546.

159. Ушаков АВ. Ультразвуковая диагностика диффузных процессов щитовидной железы. М.: Клиника доктора А.В. Ушакова. 2019; 152.

160. Ушаков АВ. Ультразвуковая диагностика диффузных процессов щитовидной железы. М.: Клиника доктора АВ Ушакова. 2020; 176.

161. Jung SJ, Kim DW. Ultrasonographic and cytopathological features of an inflammatory pseudonodule in the thyroid gland. Diagn Cytopathol. 2016; 44(9):725‐730.

162. Bonavita JA, Mayo J, Babb J, et al. Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone?. AJR Am J Roentgenol. 2009; 193(1):207‐213.

163. Прокопчук В.С. Васкуляризация нормальных и зобно изменённых щитовидных желез. Диссертация на соиск. уч. ст. к.м.н. Черновцы, 1965; 410.

164. Судаков ЮН, Берсенев ВА, Торская ИВ. Метамерно-рецепторная рефлексотерапия. К.: Здоровье. 1986; 216.

165. Köhrle J. The Colorful Diversity of Thyroid Hormone Metabolites. Eur Thyroid J. 2019; 8(3):115‐129.

166. Давыдовский ИВ. Общая патология человека. 2-е изд. М.: Медицина, 1969; 612.

167. Грабарь ПН. К вопросу об аутоантителах. Проблемы реактивности организма. Под ред. А.Д. Адо. М.: Медицина, 1968,152.

168. Kashkouli MB, Pakdel F, Kiavash V, Heidari I, Heirati A, Jam S. Hyperthyroid vs hypothyroid eye disease: the same severity and activity. Eye (Lond). 2011 Nov;25(11):1442-6.

169. Gonzalez-Aguilera B, Betea D, Lutteri L, Cavalier E, Geenen V, Beckers A, Valdes-Socin H. Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients. Arch Endocrinol Metab. 2018;62(6):609-614.

170 Wyse EP, McConahey WM, Woolner LB, Scholz DA, Kearns TP. Ophthalmopathy without hyperthyroidism in patients with histologic Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 1968 Nov;28(11):1623-9.

171. Furqan S, Haque NU, Islam N. Conversion of autoimmune hypothyroidism to hyperthyroidism. BMC Res Notes. 2014 Aug 3;7:489.

172. Joplin GF, Fraser R. Thyrotoxicosis developing in recurrent nodular goitre with focal thyroiditis. Proc R Soc Med. 1959 Mar;52(3):177-8.

173. Sukik A, Mohamed S, Habib MB, Sardar S, Tanous B, Tahtouh R, Mohamed MFH. The Unusual Late-Onset Graves’ Disease following Hashimoto’s Related Hypothyroidism: A Case Report and Literature Review. Case Rep Endocrinol. 2020 Dec 8;2020:5647273.

174. Watari J, Jassil N. Conversion of hypothyroidism to hyperthyroidism: a rare clinical phenomenon. AACE Clin Case Rep. 2020 Aug 6;6(5):e279-e281.

175. Kasagi K, Hidaka A, Endo K, Miyamoto S, Takeuchi R, Misaki T, Sakahara H, Konishi J. Fluctuating thyroid function depending on the balance between stimulating and blocking types of TSH receptor antibodies: a case report. Thyroid. 1993 Winter;3(4):315-8.

176. McLachlan SM, Rapoport B. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid. 2013;23(1):14-24.

177. Takasu N, Yamada T, Sato A, Nakagawa M, Komiya I, Nagasawa Y, Asawa T. Graves’ disease following hypothyroidism due to Hashimoto’s disease: studies of eight cases. Clin Endocrinol (Oxf). 1990 Dec;33(6):687-98.

178. Christy JH, Morse RS. Hypothyroid Graves’ disease. Am J Med. 1977 Feb;62(2):291-6.

179. McDermott MT, Kidd GS, Dodson LE, Hofeldt FD. Hyperthyroidism following hypothyroidism. Am J Med Sci. 1986 Mar;291(3):194-8.

180. Goolden AW, Davidson M, Hoffenberg R. Myxoedema preceding hyperthyroidism. Lancet. 1971 Jul 31;2(7718):268.

181. James KW. Myxoedema preceding hyperthyroidism. Lancet. 1971 Jul 17;2(7716):156.

182. Bremner WJ, Griep RJ. Graves thyrotoxicosis following primary thyroid failure. JAMA. 1976 Mar 29;235(13):1361.

183. Hochstein MA, Nair V, Nevins M. Hypothyroidism followed by hyperthyroidism. Occurrence in a patient with elevated antithyroid antibody titer. JAMA. 1977 May 16;237(20):2222.

184. Bhandarkar SD, Retnam VJ. Hyperthyroidism following hypothyroidism. J Postgrad Med. 1980 Jan;26(1):90-4.

185. Emil L, Robert EJ. Hypothyroid Grave’s Disease. South Med J. 1970;90(12):1201-1203.

186. Champion B, Gopinath B, Ma G, El-Kasissi S, Wall JR. Conversion to graves’ hyperthyroidism in a patient with hypothyroidism due to hashimoto’s thyroiditis documented by real-time thyroid ultrasonograpy. Thyroid. 2008;18(10):1135-1137.

187. Chung YH, Ou HY, Wu TJ. Development of hyperthyroidism following primary hypothyroidism: a case report. Kaohsiung J MedSci. 2004;20(4):188-191.

188. Al-Sharafi BA, Khardori R. Hyperthyroidism after hypothyroidism. SouthMed J. 2000;93(7):703-707.

189. Kohut WD, Gharib H, Anderson MW. Triiodothyronine thyrotoxicosis complicating primary hypothyroidism in a patient with autoimmune thyroiditis.Am J Med. 1982;72(5):843-846.

190. Wakakuri N, Kubo T, Kitagawa M. Hyperthyroidism after primary hypothyroidism: Follow-up with serial thyroid biopsies. ArchInternMed. 1985;145(8):1527-1528.

191. Sung LC, McDougall IR. Graves’ hyperthyroidism: spontaneous occurrence after autoimmune hypothyroidism with persistent infiltrative ophthalmopathy. Arch Intern Med. 1978;138(6):1009-1010.

192. Guansing AR, Klink DD, Engbring N. Graves’ disease following the occurrence of hypothyroidism. HenryFordHospMed J. 1980;28(2-3):152-157.

193. Skare S, Frey HMM, Konow-Thorsen R. Primary hypothyroidism followed by hyperthyroidism Five case reports. ActaEndocrinol. 1984;105(2):179-183.

194. Steel NR, Bingle JP, Ramsay ID, Kendall-Taylor P. Myxoedema followed by TSAb-induced hyperthyroidism: report of 2 cases. PostgradMed J. 1985;61(718):717-720.

195. Perrild H, Hansen JM. Hypothyroidism followed by hyperthyroidis. Lancet. 1977;2(8048):1129.

196. Rivera JV, Reyes FM. Myxedema preceding thyrotoxicosis in Graves’ disease. Bol Asoc Med P R. 1968;60(9):438-442.

197. Mäenpää J. Hypothyroidism preceding hyperthyroid Graves’ disease in two children. ActaEndocrinol. 1983;251:27-32.

198. Fatourechi V, Gharib H. Hyperthyroidism following hypothyroidism: data on six cases. ArchInternMed. 1988;148(4):976–978.

199. McDermott MT, Kidd GS, Dodson LE, Hofeldt FD. Hyperthyroidism following hyperthyroidism. Am J Med Sci. 1986;291(3):194-198.

200. Takeda K, Takamatsu J, Kasagi K, Sakane S, Ikegami Y, Isotani H, Majima T, Majima M, Kitaoka H, Iida Y. Development of hyperthyroidism following primary hypothyroidism: A case report with changes in thyroid related antibodies. ClinEndocrinol (Oxf) 1988;28(4):341-344.

201. Olckzak S, MuCulloch AJ, Clark F. Thyrotoxic graves’ disease after Primary hypothyroidism. BrMed J. 1978;2(6138):666.

202. Levine GA, Williams DE, Hershman JM, Beall GN. Case reports. Graves hyperthyroidism following myxedema in a patient with recurrent carcinoma of the colon. West J Med. 1978 Mar;128(3):240-244.

203. Olczak S, McCulloch AJ, Clark F. Thyrotoxic Graves’s disease after primary hypothyroidism. Br Med J. 1978 Sep 2;2(6138):666.

204. Ухтомский А.А. Собрание сочинений. Том I. Л.: Изд. Ленинградского ордена Ленина университета им. А.А. Жданова, 1950, 330.

205. Сорокин АА. Философский энциклопедический словарь. М.: Советская энциклопедия. 1983; 840.

206. Форд Г. Моя жизнь. Мои достижения. М.: Астрель. 2012; 349.